Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
248.50    3.50 (1.43%)
Bid:
249.00
Ask:
251.00
Spread: 2.00 (0.803%)
Market Cap: £144.97m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Regeneration Agreements

17 Apr 2007 07:01

Gleeson(M J)Group PLC17 April 2007 Tuesday 17 April 2007 MJ GLEESON GROUP PLC Financial close achieved on Stanhope Estate, Ashford PFI Gleeson (GLE.L), which is transforming itself into a specialist in housingregeneration, announces that its Chrysalis Consortium has signed Development andProject Agreements with Ashford Borough Council in Kent for the regeneration ofthe Stanhope Estate - importantly, Gleeson's first regeneration scheme in theSouth of England. Pursuant to the Development Agreement, Gleeson Homes & Regeneration South willundertake the development of 442 new homes, together with a commercial centrecomprising three retail units and a pub/restaurant, together valued at £50m. Thedevelopment will take place on 10 sites, in four phases, over five years. Thesplit of new homes is 70% (309 units) to be affordable (social rent and sharedownership) for sale to Moat Housing Group and 30% (133 units) for private sale. The Project Agreement covers the refurbishment, maintenance and management ofthe retained dwellings and public open space, together with the creation of anew Stanhope Community Centre. Pursuant to this Agreement, whose term is 30years, Gleeson's subsidiary, Gleeson Services, under its Powerminster brand,will provide facilities management services, valued at £23m. Through its PFI-focused subsidiary, Gleeson Capital Solutions, Gleeson createdthe Chrysalis Consortium to bid for this Housing Revenue Account (HRA)PFI-funded scheme. Gleeson's partners in the Consortium are the Kent-based MoatHousing Group, delivering housing management services, and Nationwide BuildingSociety, funding the scheme. Nationwide and Gleeson are partners in thesuccessful regeneration project at Grove Village in South Manchester, a £103meight year programme which was the first substantial Local Authority housingPFI, with a similar HRA structure to the Ashford PFI. Dermot Gleeson, Chairman, stated "When considering PFI-funded regenerationschemes, our ultimate aim is to secure long-term work for Gleeson Homes &Regeneration in new build housing for sale and for Gleeson Services ininstallation work and maintenance, whilst securing equity returns viaparticipation in the PFI investment. The Ashford scheme fully meets thoseobjectives. Now that Ashford is underway, Gleeson looks forward to building onthe success and high potential of its regeneration business in the North ofEngland by involvement in further schemes throughout the country." -Ends- Notes for Editors: In addition to the Stanhope Estate in Ashford, Gleeson is currently active atfive regeneration sites: Grove Village in South Manchester, Beswick in EastManchester, Norfolk Park in Sheffield, Cleveland Street in Liverpool, andNorthumberland Street in Liverpool. Four further regeneration sites, bringing the total to 10, are expected by theBoard to be active in the year to 30 June 2008: Cheshire Care Homes, NorthHuyton in Merseyside, Gorton Monastery in East Manchester, and St. Mary's inOldham. In addition, Gleeson is the preferred developer for the whole of theCity Centre South Zone in Liverpool (of which Cleveland Street andNorthumberland Street are parts), which potentially involves the development of1,000 acres in a programme extending to 2017. Photograph: A photograph of the Stanhope Estate, Ashford is available from Charles Ponsonbyat Bankside Consultants on charles.ponsonby@bankside.com. Enquiries: M J Gleeson Group plc 01252-360 300Paul Wallwork (Group Chief Executive)Chris Holt (Financial Director) Bankside Consultants LimitedCharles Ponsonby 020-7367 8851 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
2nd Jun 20267:00 amRNSBoard Committee Changes
7th May 20264:36 pmRNSDirector/PDMR Shareholding
7th May 20262:49 pmRNSDirector/PDMR Shareholding
1st May 20267:00 amRNSTrading Update
23rd Apr 20267:00 amRNSNotice of Trading Updates and FY2026 Results
14th Apr 20269:34 amRNSDirector/PDMR Shareholding
14th Apr 20269:33 amRNSDirector/PDMR Shareholding
6th Mar 20263:19 pmRNSDirector/PDMR Shareholding
2nd Mar 20264:04 pmRNSHolding(s) in Company
11th Feb 20267:00 amRNSResults for the half year ended 31 December 2025
9th Feb 202610:47 amRNSDirector/PDMR Shareholding
9th Feb 20267:00 amRNS-RPresentation of HY Results on Engage Investor
16th Jan 20267:00 amRNSTrading Update and Notice of Results
6th Jan 20264:40 pmRNSDirector/PDMR Shareholding
9th Dec 202511:31 amRNSDirector/PDMR Shareholding
25th Nov 20251:01 pmRNSDirector/PDMR Shareholding
20th Nov 20253:25 pmRNSHolding(s) in Company
14th Nov 20252:46 pmRNSResult of AGM
14th Nov 20257:01 amRNSAppointment of Non-Executive Director
14th Nov 20257:00 amRNSAGM Trading Update
6th Nov 20255:09 pmRNSDirector/PDMR Shareholding
24th Oct 20254:16 pmRNSDirector/PDMR Shareholding
23rd Oct 20255:07 pmRNSDirector/PDMR Shareholding
20th Oct 20254:09 pmRNSDirector/PDMR Shareholding
17th Oct 20257:00 amRNSNotice of AGM
7th Oct 20253:18 pmRNSDirector/PDMR Shareholding
22nd Sep 20255:01 pmRNSREPLACEMENT: Director/PDMR Shareholding
18th Sep 20257:00 amRNS-RPresentation on Engage Investor Platform
17th Sep 20254:23 pmRNSDirector/PDMR Shareholding
16th Sep 20257:00 amRNSAudited results for the year ended 30 June 2025
9th Sep 202510:45 amRNSDirector/PDMR Shareholding
13th Aug 20257:00 amRNSNotice of Full-Year Results and Presentation
7th Aug 20253:05 pmRNSDirector/PDMR Shareholding
10th Jul 20254:17 pmRNSDirector/PDMR Shareholding
9th Jul 20251:05 pmRNSHolding(s) in Company
8th Jul 20254:00 pmRNSDirector/PDMR Shareholding
7th Jul 20253:11 pmRNSHolding(s) in Company
4th Jul 20257:00 amRNSDirectorate Change
4th Jul 20257:00 amRNSTrading Statement
12th Jun 20253:21 pmRNSDirector/PDMR Shareholding
10th Jun 202511:34 amRNSDirector/PDMR Shareholding
6th Jun 20257:00 amRNSHolding(s) in Company
4th Jun 20255:06 pmRNSDirector/PDMR Shareholding
3rd Jun 20257:03 amRNSTrading Update
7th May 20252:33 pmRNSDirector/PDMR Shareholding
24th Apr 20257:00 amRNSDirectorate Change
8th Apr 20255:22 pmRNSDirector/PDMR Shareholding
8th Apr 20255:17 pmRNSDirector/PDMR Shareholding
6th Mar 20254:52 pmRNSDirector/PDMR Shareholding
5th Mar 20252:54 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.